Technology

Rocket Lab Secures $190M Hypersonic Deal, Stock Slides on $1B Share Sale Plan

Rocket Lab shares declined premarket Monday following a record $190 million hypersonic test contract award and a new plan to potentially sell up to $1 billion in stock. The company's backlog now exceeds $2 billion.

Sarah Chen · · · 3 min read · 0 views
Rocket Lab Secures $190M Hypersonic Deal, Stock Slides on $1B Share Sale Plan
Mentioned in this article
XLK $138.78 +1.45%

Shares of Rocket Lab Corporation traded lower ahead of the market open on Monday, March 23, 2026, shedding approximately 6.5% to hover near $67.23. The decline came as investors digested two significant announcements: a major new defense contract and a substantial equity financing plan.

Record Contract and Capital Raise

The aerospace company secured a landmark $190 million contract from the U.S. military for hypersonic flight testing, marking its largest launch deal to date. Concurrently, Rocket Lab filed a shelf registration statement, creating the potential to offer and sell up to $1 billion worth of its common stock over time. This dual news highlights the firm's strategic pivot toward defense and its ongoing need for capital to fund growth initiatives.

Backlog Swells Past $2 Billion

The new award, part of the Multi-Service Advanced Capability Hypersonic Test Bed (MACH-TB 2.0) program, involves a block buy for 20 missions of its Hypersonic Accelerator Suborbital Test Electron (HASTE) vehicle over the next four years. HASTE utilizes a modified version of Rocket Lab's Electron rocket to conduct suborbital tests at speeds exceeding Mach 5, or five times the speed of sound. The company reports a perfect mission record for HASTE flights to date.

This contract significantly bolsters Rocket Lab's order book. The company ended 2025 with a record backlog of $1.85 billion. With the addition of the HASTE missions and other defense orders, the total backlog for launch services and space systems now surpasses $2 billion. Rocket Lab indicated that the 20 HASTE missions helped drive first-quarter 2026 launch sales to 28, nearly matching the total number of launches sold in all of 2025.

Strategic Defense Push and Market Context

The award underscores Rocket Lab's deepening involvement in national security space. The company, alongside Stoke Space, was selected for the U.S. Space Force's National Security Space Launch Phase 3 Lane 1 program last year, positioning it to compete for future government missions against larger rivals like SpaceX, Blue Origin, and United Launch Alliance.

Peter Beck, Rocket Lab's Chief Executive, stated the contract advances "speed and affordability" in hypersonic capabilities. Officials echoed the strategic importance, with the Test Resource Management Center's George Rumford calling MACH-TB "an essential tool" for developing future hypersonic technologies. Michael Johns, Senior Vice President at Kratos Defense & Security Solutions, which leads a task area in the program, noted the U.S. is at a "critical point" requiring fast and cost-effective hypersonic testing.

Commercial Demand and Financial Outlook

Despite the focus on defense, commercial launch activity continues. The company successfully completed its 84th Electron rocket flight on Friday, March 20, deploying a new StriX synthetic-aperture radar satellite for Japanese Earth observation company Synspective. This marked the eighth mission for Synspective, which has now booked a total of 27 launches with Rocket Lab, signaling sustained demand in the commercial satellite sector.

Financially, Rocket Lab is coming off a record year. The company reported 2025 revenue of $601.8 million. For the first quarter of 2026, management has provided revenue guidance in the range of $185 million to $200 million. The firm concluded 2025 with a strong cash position of $828.7 million in cash and cash equivalents.

Challenges and Investor Considerations

The path forward is not without hurdles. Rocket Lab recently announced a delay for the inaugural launch of its larger Neutron rocket to the fourth quarter of 2026, following a failed test of a first-stage tank last month. Furthermore, the newly announced at-the-market equity program, established on March 17, introduces a potential dilution risk for existing shareholders should the company choose to sell shares under the arrangement.

As the company balances the rapid tempo of Electron and HASTE launches with the development of the Neutron platform, investor attention remains fixed on its contract pipeline, execution cadence, and capital management strategy. The premarket stock movement reflects the market's immediate calculus weighing a substantial new revenue stream against the future impact of potential equity dilution.

This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Market data may be delayed. Always conduct your own research and consult a licensed financial advisor before making investment decisions.

Related Articles

View All →